Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Op-Eds
Cruel and Unusual: People for the Ethical Treatment of Animals
On January 9, two employees of the group People for the Ethical Treatment of Animals (PETA) will appear in court to answer felony…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. ENERGY A conflict between Ukraine and Russia threatens to undermine natural gas supplies to much of…
Op-Eds
Ominous Prospects for Aging
A recent article in the Wall Street Journal described “a growing backlash against the pharmaceutical industry that is already affecting the development and…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. TELECOMMUNICATIONS Technology security firms are warning computer users to beware of a flaw in Microsoft Windows which…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. LABOR The New York City Transport Workers Union’s executive board votes to approve a new…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. BIOTECHNOLOGY Researchers in Iran announce the impending birth of that nation’s first generation of…